Neorgana’s research and development efforts focusing on neural crest cells (NCCs) represent an innovative approach to addressing various neurological conditions. NCCs arise during embryonic development and can differentiate into a diverse range of cell types, including neurons and glial cells.
By focusing on neural crest cells, We aim to deepen our understanding of neurological disorders and develop groundbreaking treatments that could change the landscape of care for affected individuals.
At Neorgana, we are dedicated to revolutionizing pain management by developing alternatives that do not rely on opioids. Our Research and Development division is actively exploring the potential of biologicals to provide safer and more effective pain relief solutions.
The increasing concern over opioid dependency and associated health risks has fueled our commitment to seek novel approaches. By harnessing the power of biologicals, we aim to tap into the body’s natural pain regulation mechanisms, offering effective relief without the side effects of traditional pain medications.
Through cutting-edge research and collaboration with leading experts, we are focusing on innovative therapies that prioritize patient safety and well-being. Our goal is to develop solutions that not only alleviate pain but also support overall health.
We are excited about the potential impact of our work in the realm of pain management. Stay tuned for updates as we continue to make strides in creating a healthier, opioid- free future.
LUNES - JUEVES
10:00am a 14:00pm
16:30pm a 20:30pm
VIERNES
10:00am a 14:00pm
Las Palmas de Gran Canaria, España.
En Neorgana, estamos comprometidos con la investigación y el desarrollo de terapias de vanguardia basadas en células madre.